Samiksha Jaiswal (Editor)

Medochemie

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Industry
  
Pharmaceutical

Website
  
Medochemie.com

Revenue
  
500 million USD

Number of employees
  
1,250

Area served
  
Worldwide

Headquarters
  
Limassol

Founded
  
1976

Type
  
Privately held company

Medochemie wwwfinancialmirrorcomuserfilesmedochemie1jpg

Key people
  
Andreas Pittas Chairman & CEO

Products
  
Pharmaceuticals, over-the-counter medicines

Profiles

Medochemie corporate video 2014 www medochemie com


Medochemie Ltd is a multinational generics pharmaceutical and consumer healthcare company headquartered in Limassol, Cyprus. Medochemie develops, licenses, manufactures, markets, and distributes branded generic products as well as their own patented brands.

Contents

Medochemie generic pharmaceutical company


History

Medochemie was established in 1976 by a Cypriot entrepreneur Dr Andreas Pittas with eight employees and three machines: for tablet making, capsule filling and packaging. Medochemie is a founding member of the European Generic Medicines Association (EGA).

Operations

Medochemie employed 1,250 people in 2009. Medochemie has eleven manufacturing plants and facilities. Nine are located in Cyprus, one in the Netherlands, and one in Vietnam. The company maintains 3,800 marketing authorization licenses for 630 different pharmaceutical products, classified in over 10 therapeutic categories. Its global headquarters are based at Medochemie House in Limassol's industrial area.

References

Medochemie Wikipedia